Abstract
P76.15 Osimertinib Improved Overall Survival in mEGFR NSCLC Patients With Leptomeningeal Metastases Regardless of T790M Mutational Status
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have